Nairobi — The war against prostate cancer could soon be won if a drug developed in America works. The drug, Ipilimumab, developed at the Mayo Clinic in the US, is said to have had such an unexpected effect on patients who agreed to the clinical trials that researchers decided to release the details of the two cases before the tests were even complete. According to the UK's Independent newspaper, two patients with inoperable prostate cancer made dramatic recoveries after receiving a single dose of the experimental drug. The two were part of 108 men who had volunteered to undergo clinical tests of the drug at the clinic. The Ipilimumab trial is being equated to that of the first pilot breaking the sound barrier. "This is one of the Holy Grails of prostate cancer research. We have been looking for this for years," said Dr Eugene... [read full story]
|
RELATED
|
|
Nairobi — The war against prostate cancer could soon be won if a drug developed in America works. The drug, Ipilimumab, developed at the Mayo Clinic in the US, is said to have had such an unexpected effect on patients who...
By DANIEL WESANGULAPosted Saturday, July 4 2009 at 22:30 But experts urge caution saying the drug, Ipilimumab, needs more tests The war against prostate cancer could soon be won if a drug developed in America works. The drug,...
War, Terrorism & Civil Disorder, Male Health, Ambulatory Health Care, Cancer by Body Location, Current Conflicts, Scientific Discoveries, Health Care, Cancers, Patients, Cancer Therapy, Prostate Cancer, Female Health, Medical Research, Conflict in Kenya, Horn of Africa, Kenya, Nairobi
